AHR - aryl hydrocarbon receptor Gene
Species: Macaca fascicularis
Gene Type: protein coding
Gene ID: 102129171
AHR Products (1)
| mRNA | Protein | Name |
|---|---|---|
| XM_005550045.3 | XP_005550102.2 | aryl hydrocarbon receptor |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
aryl hydrocarbon receptor |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(11)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-109044 | Tapinarof | Agonist | 99.95% | Unkown |
| HY-A0083 | Methacholine chloride | Agonist | ≥98.0% | Yes |
| HY-N0178 | Diosmin | Agonist | 98.62% | Yes |
| HY-B0311 | Carbidopa | Modulator | 99.84% | Yes |
| HY-W017113 | 2-Mercaptobenzothiazole | 99.85% | Yes | |
| HY-B0311A | Carbidopa monohydrate | Modulator | 99.84% | Yes |
| HY-B0678 | Metaxalone | 99.77% | Unkown | |
| HY-17357 | Nepafenac | Inhibitor | 99.56% | Unkown |
| HY-17479 | Amfenac | / | Unkown | |
| HY-A0083B | Methacholine bromide | Agonist | / | Unkown |
| HY-B0678R | Metaxalone (Standard) | / | Unkown |
Clinical Phase
Bioactive Molecules
(11)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-N0170 | Indole-3-carbinol | 99.16% | Phase 3 | |
| HY-B2132 | Tryptamine | 99.89% | Phase 3 | |
| HY-W013053 | Dibenz[a,h]anthracene | Inducer | 98.0% | Phase 3 |
| HY-15001 | Stemregenin 1 | Antagonist | 99.95% | Phase 2 |
| HY-16031B | AFP464 dihydrochloride | 99.45% | Phase 2 | |
| HY-16031 | AFP464 free base | / | Phase 2 | |
| HY-16031A | AFP464 | / | Phase 2 | |
| HY-135829 | BAY 2416964 | Antagonist | 99.59% | Phase 1 |
| HY-111449 | BAY-218 | Antagonist | 99.78% | Phase 1 |
| HY-N0170R | Indole-3-carbinol (Standard) | 98.31% | Phase 1 | |
| HY-136220 | AHR antagonist 5 | Antagonist | 98.05% | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(168)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-12684 | CH-223191 | Antagonist | 99.82% | Unkown |
| HY-12028 | PD98059 | 99.94% | Unkown | |
| HY-15484 | Pifithrin-α hydrobromide | 98.58% | Unkown | |
| HY-12451 | FICZ | Agonist | 99.42% | Unkown |
| HY-W028393 | Indole-3-pyruvic acid | Agonist | 99.55% | Unkown |
| HY-19317 | ITE | Agonist | 99.27% | Unkown |
| HY-102023 | GNF351 | Antagonist | 99.87% | Unkown |
| HY-W011910 | Potassium 1H-indol-3-yl sulfate | 99.95% | Unkown | |
| HY-W015273A | trans-3-Indoleacrylic acid | Inhibitor | 99.77% | Unkown |
| HY-114740 | β-Naphthoflavone | 99.86% | Unkown | |
| HY-W007355 | Skatole | 99.99% | Unkown | |
| HY-141609 | IK-175 | Inhibitor | 99.89% | Unkown |
| HY-122208 | SGA360 | Inhibitor | 99.93% | Unkown |
| HY-133677 | Mono(2-ethyl-5-hydroxyhexyl) phthalate | 99.03% | Unkown | |
| HY-103220 | 6,2',4'-Trimethoxyflavone | Antagonist | 98.02% | Unkown |
| HY-W011338 | Benzyl butyl phthalate | Activator | 97.0% | Unkown |
| HY-134217 | KYN-101 | Inhibitor | 98.03% | Unkown |
| HY-119019 | ASB14780 | Inhibitor | 99.58% | Unkown |
| HY-B0845 | Prochloraz | 99.85% | Unkown | |
| HY-W014502 | D-Kynurenine | Agonist | 99.94% | Unkown |
| HY-W014075 | 1-Hydroxypyrene | 99.38% | Unkown | |
| HY-103221 | MeBIO | 98.0% | Unkown | |
| HY-18619 | YL-109 | Modulator | 98.91% | Unkown |
| HY-132429S | Potassium 1H-indol-3-yl sulfate-d5 | 99.77% | Unkown | |
| HY-112628 | CAY10464 | Antagonist | 99.77% | Unkown |
| HY-N1939 | Icariside I | 98.76% | Unkown | |
| HY-144339 | AhR agonist 2 | 99.89% | Unkown | |
| HY-135750 | VAF347 | Agonist | 99.75% | Unkown |
| HY-12545 | Brevetoxin-3 | Activator | 95.0% | Unkown |
| HY-112629 | PDM2 | Antagonist | 98.96% | Unkown |
| HY-117532 | PenCB | Inducer | 99.82% | Unkown |
| HY-77278 | 25-Hydroxytachysterol3 | Agonist | 98.07% | Unkown |
| HY-15001G | Stemregenin 1 (GMP) | Antagonist | / | Unkown |
| HY-N0914 | Ajugol | 99.80% | Unkown | |
| HY-111450 | CB7993113 | Antagonist | 98.0% | Unkown |
| HY-D0932 | Sudan IV | 98.0% | Unkown | |
| HY-G0006 | Omeprazole sulfide | 99.88% | Unkown | |
| HY-W014701 | 1,4-Dihydroxy-2-naphthoic acid | 99.60% | Unkown | |
| HY-117102 | ANI-7 | Activator | 99.01% | Unkown |
| HY-G0007 | Omeprazole sulfone | Control | 99.23% | Unkown |
| HY-118438 | 10-Cl-BBQ | Agonist | 99.46% | Unkown |
| HY-W718300 | Indole-3-pyruvic acid-d5 | 96.31% | Unkown | |
| HY-W011910S | Potassium 1H-indol-3-yl sulfate-d4 | Activator | 99.9% | Unkown |
| HY-17663 | KMR-206 | 98.86% | Unkown | |
| HY-W011338S | Benzyl butyl phthalate-d4 | 98.38% | Unkown | |
| HY-N0586A | Norisoboldine hydrochloride | Agonist | 99.72% | Unkown |
| HY-124421 | 5F-203 | Inducer | 98.04% | Unkown |
| HY-RS00483 | AHR Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-B0973 | Dibenzothiophene | Inhibitor | 99.92% | Unkown |
| HY-112627 | CAY 10465 | Agonist | 98.30% | Unkown |
| HY-114682 | Lenperone | Antagonist | 98.11% | Unkown |
| HY-N4095 | Brevifolincarboxylic acid | Inhibitor | 99.90% | Unkown |
| HY-130256 | β-NF-JQ1 | Degrader | 98.05% | Unkown |
| HY-105791 | Sulazepam | 99.56% | Unkown | |
| HY-147128 | PY109 | Agonist | 99.15% | Unkown |
| HY-34505 | 1-Methyl-5-pyrazolecarboxylic acid | 99.83% | Unkown | |
| HY-W012278 | Benz[a]anthracene | Ligand | 99.90% | Unkown |
| HY-111441 | 1,4-Chrysenequinone | Activator | 99.97% | Unkown |
| HY-120377 | CYP1A1 inhibitor 8a | Inhibitor | 98.00% | Unkown |
| HY-124404 | 12(R)-HETE | 99.90% | Unkown | |
| HY-125019 | iJak-381 | Inhibitor | 99.86% | Unkown |
| HY-135831 | AHR antagonist 2 | Antagonist | 99.30% | Unkown |
| HY-B0311AS | Carbidopa-d3 monohydrate | Modulator | 98.53% | Unkown |
| HY-W014075S | 1-Hydroxypyrene-d9 | 99.95% | Unkown | |
| HY-W764758 | 3-OH-Kynurenamine dihydroiodide | Activator | 99.56% | Unkown |
| HY-12028R | PD98059 (Standard) | 99.72% | Unkown | |
| HY-103222 | DiMNF | Modulator | 98.46% | Unkown |
| HY-103223 | Phortress | Inducer | 98.19% | Unkown |
| HY-N0586 | Norisoboldine | Agonist | 99.65% | Unkown |
| HY-W251708 | AHR 10240 | / | Unkown | |
| HY-114740R | β-Naphthoflavone (Standard) | 99.49% | Unkown | |
| HY-RS16533 | Ahr Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-100242 | Mivotilate | Activator | 99.58% | Unkown |
| HY-104026CS | L-Kynurenine-13C10 sulfate hemihydrate | Agonist | 99.90% | Unkown |
| HY-118474 | GW 610 | Activator | 99.78% | Unkown |
| HY-118780 | CHD-5 | Antagonist | 98.0% | Unkown |
| HY-17357S | Nepafenac-d5 | Inhibitor | 98.84% | Unkown |
| HY-N10123 | Indolokine A5 | Agonist | 98.0% | Unkown |
| HY-N6264 | 26-Deoxyactein | Inhibitor | 99.76% | Unkown |
| HY-W014502R | D-Kynurenine (Standard) | Agonist | 99.99% | Unkown |
| HY-W046846 | Corannulene | Agonist | 97.31% | Unkown |
| HY-W338764 | AHR agonist 3 | 99.79% | Unkown | |
| HY-133677S | Mono(2-ethyl-5-hydroxyhexyl) phthalate-d4 | 96.23% | Unkown | |
| HY-154825 | 20-Hydroxyvitamin D3 | ≥98.0% | Unkown | |
| HY-W095381 | N-Methylscatole | Agonist | 98.45% | Unkown |
| HY-131340 | LASSBio-1632 | Inhibitor | / | Unkown |
| HY-136220A | AHR antagonist 5 hemimaleate | Antagonist | / | Unkown |
| HY-101745B | Rocastine fumarate | / | Unkown | |
| HY-101802 | Fluzinamide | / | Unkown | |
| HY-104026B | L-Kynurenine sulfate | Agonist | / | Unkown |
| HY-106487 | Pridefine | Inhibitor | / | Unkown |
| HY-111157 | Dezinamide | / | Unkown | |
| HY-114682A | Lenperone hydrochloride | Antagonist | / | Unkown |
| HY-116148 | AHR-11797 | / | Unkown | |
| HY-116638 | AHR-5333 | Inhibitor | / | Unkown |
| HY-116638A | AHR-5333 mandelate | Inhibitor | / | Unkown |
| HY-117774 | AHR-2244 hydrochloride | / | Unkown | |
| HY-118792 | AHR activator 1 | / | Unkown | |
| HY-119018 | AHR-6293 | Inhibitor | / | Unkown |
| HY-119960 | AHR-10037 | Inhibitor | / | Unkown |
| HY-120677 | AHR-15010 | Inhibitor | / | Unkown |
| HY-123432 | AHR-13268D | Inhibitor | / | Unkown |
| HY-123461 | Sul-121 hydrochloride | Inhibitor | / | Unkown |
| HY-124021 | Benzyl 2-naphthyl ether | 99.44% | Unkown | |
| HY-125926A | (S)-2-Ketodoxapram | / | Unkown | |
| HY-125926S | 2-Ketodoxapram-d5 | / | Unkown | |
| HY-129305 | Tampramine fumarate | Inhibitor | / | Unkown |
| HY-130269 | β-Naphthoflavone-CH2-OH | / | Unkown | |
| HY-130270 | AhR Ligand-Linker Conjugates 1 | / | Unkown | |
| HY-130842 | β-Naphthoflavone-CH2-Br | / | Unkown | |
| HY-132974 | Aminoflavone | / | Unkown | |
| HY-135671 | AhR modulator-1 | / | Unkown | |
| HY-135830 | AHR antagonist 4 | Antagonist | / | Unkown |
| HY-136876 | AHR-12234 citrate | / | Unkown | |
| HY-136891 | AHR-16303B | / | Unkown | |
| HY-139117 | 6,2′,4′-Trimethoxyflavone | Antagonist | / | Unkown |
| HY-155505 | AHR agonist 4 | Agonist | / | Unkown |
| HY-156908 | 3-OH-Kynurenamine | Activator | / | Unkown |
| HY-158167 | AhR agonist 5 | Agonist | / | Unkown |
| HY-158168 | AhR agonist 6 | Agonist | / | Unkown |
| HY-158169 | AhR agonist 7 | Agonist | / | Unkown |
| HY-161649 | hCYP1B1-IN-2 | Inhibitor | / | Unkown |
| HY-168033 | AhR agonist 8 | Agonist | / | Unkown |
| HY-169753 | AHR-IN-1 | Inhibitor | / | Unkown |
| HY-17479B | Amfenac sodium | / | Unkown | |
| HY-175785 | X15695 | 98.45% | Unkown | |
| HY-176771 | Tapinarof prodrug-1 | / | Unkown | |
| HY-178053 | AHR agonist 10 | / | Unkown | |
| HY-181472 | 10(11)-Cl-BBQ | / | Unkown | |
| HY-181629 | ZSTK3744 | / | Unkown | |
| HY-181629A | ZSTK3744 hydrochloride | / | Unkown | |
| HY-182495 | Penisimplicissin | Inhibitor | / | Unkown |
| HY-19826 | Isofistularin-3 | / | Unkown | |
| HY-A0083C | Methacholine iodide | Agonist | / | Unkown |
| HY-B0311D | Carbidopa hydrochloride | Modulator | / | Unkown |
| HY-B0311S1 | Carbidopa-d3-1 | Modulator | / | Unkown |
| HY-B0678S | Metaxalone-d3 | 98.0% | Unkown | |
| HY-B0678S1 | Metaxalone-d6 | / | Unkown | |
| HY-B0973S | Dibenzothiophene-d8 | Inhibitor | / | Unkown |
| HY-G0007S | Omeprazole sulfone-d3 | Control | / | Unkown |
| HY-G0007S1 | Omeprazole sulfone-13C,d3 | Control | / | Unkown |
| HY-N12537A | (2R,3S)-PD-1/PD-L1-IN-38 | / | Unkown | |
| HY-N16465 | Cinnamtannin D1 | Inhibitor | / | Unkown |
| HY-W716464 | Prochloraz-d7 | / | Unkown | |
| HY-101745 | Rocastine | Antagonist | / | Unkown |
| HY-104026BS | L-Kynurenine-13C10 sulfate | Agonist | / | Unkown |
| HY-107063 | AHR-1911 | Activator | 99.66% | Unkown |
| HY-109044S | Tapinarof-d5 | Agonist | / | Unkown |
| HY-118910 | AHR-14310C | Antagonist | / | Unkown |
| HY-119991 | AHR-9294 | Inhibitor | / | Unkown |
| HY-125926S1 | 2-Ketodoxapram-d4 | / | Unkown | |
| HY-128229 | AHR antagonist 6 | Antagonist | / | Unkown |
| HY-129247 | Versicolorin A | / | Unkown | |
| HY-130456 | AHR 10718 | Inhibitor | / | Unkown |
| HY-148637 | Picoberin | Agonist | / | Unkown |
| HY-163665 | AHR antagonist 8 | / | Unkown | |
| HY-167214 | (+)-Ketodoxapram | / | Unkown | |
| HY-170514 | 1,2,3,7,8,9-Hexachlorodibenzofuran | Ligand | / | Unkown |
| HY-177563 | AhR modulator-2 | Activator | / | Unkown |
| HY-20888 | 3'-Methoxy-4'-nitroflavone | / | Unkown | |
| HY-B0845R | Prochloraz (Standard) | / | Unkown | |
| HY-D0932S | Sudan IV-d6 | / | Unkown | |
| HY-N16435 | Plumericin | / | Unkown | |
| HY-RS22964 | Ahr Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-U00010 | Dazopride | / | Unkown | |
| HY-W007355S2 | Skatole-13C6 | / | Unkown | |
| HY-W587465 | 9,10-Dichlorophenanthrene | / | Unkown | |
| HY-W714200 | Neburon | / | Unkown |